Page 5 of 7

BI13.1-5 | Miscellaneous — Summary & Reflection

REFLECT

Take a moment to connect what you've learned to real life:

  1. Cancer and p53: Next time you hear about a cancer diagnosis, think about which of the two "accelerator/brake" systems failed. Can you recall the three ways an oncogene can be activated?
  1. Alcohol metabolism: Have you or anyone you know noticed that some people flush red after even a small amount of alcohol? This is due to acetaldehyde accumulation (often from a genetic variant of aldehyde dehydrogenase common in East Asian populations). How does this connect to the disulfiram reaction?
  1. HIV: Antiretroviral therapy targets multiple enzymes in the HIV life cycle. Can you name at least three drug targets from the life cycle you learned?
  1. AI in the lab: The next time you get a blood test result, consider: was an AI algorithm involved in validating that result before it reached your doctor?

KEY TAKEAWAYS

Key Takeaways — Your Study Checklist:

  1. Oncogenesis is the transformation of normal cells to cancer cells, driven by oncogenes (stuck accelerators like RAS, MYC) and loss of tumour suppressors (failed brakes like p53) — BI13.1
  1. Tumour markers (AFP, CEA, CA-125, PSA, HCG) are proteins used for cancer screening, diagnosis, and monitoring — but none is 100% specific. Cancer therapy targets oncogene products (imatinib, trastuzumab) and metabolic pathways (antimetabolites) — BI13.2
  1. HIV is a retrovirus that uses reverse transcriptase to convert RNA → DNA, targets CD4+ cells via gp120, and causes metabolic derangements (wasting, dyslipidaemia, oxidative stress) as it progresses to AIDS — BI13.3
  1. Alcohol is metabolised by ADH (main), MEOS, and catalase, producing toxic acetaldehyde and flooding the liver with NADH. Chronic alcoholism causes fatty liver → hepatitis → cirrhosis. Remember: FALL-HUG — BI13.4
  1. AI in biochemistry labs enables autoverification, quality control, pattern recognition, predictive analytics, and reference range optimisation — always with human oversight — BI13.5